The secondary structure peptidomimetic approach is a rational way to develop novel nonpeptide pharmaceutical agents based upon biologically significant proteinaceous leads. A part of this approach elaborated in this laboratory over the past ten years is reviewed along with the recent developments in this field.
No takes yet. Share an insight, caveat, or question.
Eguchi et al. (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: